Effect of Pueraria mirifica on vaginal health
Authors:
- Jittima ManonaiJMJittima Manonai
- Apichart ChittacharoenACApichart Chittacharoen
- Urusa TheppisaiUTUrusa Theppisai
- Hathai TheppisaiHTHathai Theppisai
- 1 September 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Menopause
- Vol. 14 (5) , 919-924
Abstract
To evaluate the effect of Pueraria mirifica on vaginal symptoms, vaginal health index, vaginal pH, and vaginal cytology in healthy postmenopausal women. A randomized, double-blind, placebo-controlled study. Healthy postmenopausal women, age 45 to 60 years old, were enrolled voluntarily and randomly received 20, 30, or 50 mg of Pueraria mirifica in capsules or placebo in identical capsules once daily for 24 weeks. After 24 weeks of treatment, 71 women were evaluated. Fifty-one of 71 randomly received one of the three doses of Pueraria mirifica, and the remaining 20 received placebo. The mean vaginal dryness symptom in the Pueraria mirifica group decreased after 12 weeks of treatment. Pueraria mirifica increased vaginal maturation index (parabasal:intermediate:superficial cells) from 46:43:11 to 11:65:24 after 24 weeks of treatment. There was no significant difference of adverse effects between the Pueraria mirifica and placebo groups in this study. Pueraria mirifica was proven to exhibit estrogenicity on vaginal tissue, to alleviate vaginal dryness symptoms and dyspareunia, to improve signs of vaginal atrophy, and to restore the atrophic vaginal epithelium in healthy postmenopausal women.Keywords
This publication has 26 references indexed in Scilit:
- Recent reversal of trends in hormone therapy use in a European populationMenopause, 2006
- Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative studyMenopause, 2006
- Effect of pure genistein on bone markers and hot flushesClimacteric, 2005
- Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal womenFertility and Sterility, 2005
- Estrogenicity of the Isoflavone Metabolite Equol on Reproductive and Non-Reproductive Organs in Mice1Biology of Reproduction, 2004
- Prevalence of sexual dysfunction in a cohort of middle-aged women: influences of menopause and hormone replacement therapyJournal of Obstetrics and Gynaecology, 2003
- A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometriumJournal of the Society for Gynecologic Investigation, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Isoflavonoids from Pueraria mirifica and their Estrogenic ActivityPlanta Medica, 2000
- THE EFFECT OF MIROESTROL ON VAGINAL CORNIFICATION, PITUITARY FUNCTION AND PREGNANCY IN THE RATJournal of Endocrinology, 1961